Europe PET-CT Scanner Device Market Size, Share & Industry Trends Analysis Report By Slice Count, By Isotope/Detector Type, By Service Provider, By Type, By Application, By Country and Growth Forecast, 2021-2027

The Europe PET-CT Scanner Device Market is expected to witness market growth of 5.1% CAGR during the forecast period (2021-2027).

Leading players, such as United Imaging, are effectively employing AI to achieve their objectives and is the major focus of substantial investment by the company, following its declaration of creating a new standard in molecular imaging and redefining nuclear medicine in 2020. Other prominent players, such as Bruker Corporation, Siemens Healthineers, GE Healthcare, Mediso Ltd, and others, are following the medical device innovation trend to improve the utility of medical scanning equipment, which is expected to open new growth avenues for the market.

The industry is likely to benefit as PET and X-ray transmission computed tomography (CT) scans become more widely used. In addition, this advanced technology lowers acquisition time, enables precise attenuation correction, and allows for fusion imaging, all of which contribute to high diagnostic sensitivity and specificity. Moreover, by defining prognostic and treatment monitoring capabilities of the functional and metabolic information provided by conventional nuclear imaging techniques, the combination of PET and CT aids in improved disease staging.

Because of the large number of deployed devices and the presence of major industry players such as Koninklijke Philips N.V., Siemens AG, and others in the region, the regional market is expected to witness the influx of innovative and technologically advanced devices in the upcoming years. According to the European Association of Nuclear Medicine (EANM) Annual Congress, there were 577 PET and/or PET/CT providers in Western Europe in 2012, with PET/CT accounting for 92 percent of the installed systems.

Furthermore, the PET-CT installed base is shifting away from larger institutions and toward settings like general hospitals and private practice. In addition, increased government funding is another important aspect of technology adoption. In England, for example, PET-CT is funded centrally by the National Health Service (NHS) England as of August 2015. Moreover, some of the key trends of the regional market include rising chronic illness prevalence and favorable reimbursement scenarios. Therefore, these aspects are set to propel the growth of the regional PET-CT scanner market during the forecasting period.

The Germany market dominated the Europe PET-CT Scanner Device Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $174.8 million by 2027. The UK market is exhibiting a CAGR of 4.2% during (2021 - 2027). Additionally, The France market is expected to display a CAGR of 5.9% during (2021 - 2027).

Based on Slice Count, the market is segmented into Medium Slice Cardiology (64 Slices), Low Slice Cardiology (< 64 Slices), and High Slice Cardiology (>64 Slices). Based on Isotope/Detector Type, the market is segmented into Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others. Based on Service Provider, the market is segmented into Hospitals, Diagnostic Centers, and Research Institutes. Based on Type, the market is segmented into Stationary Scanners and Portable Scanners/Mobile Scanners. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Toshiba Corporation, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Shimadzu Corporation, Positron Corporation, PerkinElmer, Inc., Mediso Ltd., and Hitachi, Ltd. (Hitachi Healthcare).

Scope of the Study

Market Segments Covered in the Report:

By Slice Count

• Medium Slice Cardiology (64 Slices)
• Low Slice Cardiology (< 64 Slices)
• High Slice Cardiology (>64 Slices)

By Isotope/Detector Type

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• Gallium
• Thallium
• Others

By Service Provider

• Hospitals
• Diagnostic Centers
• Research Institutes

By Type

• Stationary Scanners
• Portable Scanners/Mobile Scanners

By Application

• Oncology
• Cardiology
• Neurology
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Bruker Corporation
• Toshiba Corporation
• Siemens Healthineers AG (Siemens AG)
• General Electric (GE) Co. (GE Healthcare)
• Koninklijke Philips N.V.
• Shimadzu Corporation
• Positron Corporation
• PerkinElmer, Inc.
• Mediso Ltd.
• Hitachi, Ltd. (Hitachi Healthcare)

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free